Should the extent of lobular neoplasia on core biopsy influence the decision for excision?

Breast Journal

Volumn 13, Issue 1, 2007, Pages 55-61

  Esserman, Lisa E ^a,b   Lamea, Ladan ^a   Tanev, Silvio ^a   Poppiti, Robert ^a  

^a MOUNT SINAI MEDICAL CENTER   (United States)

^b Mount Sinai Comprehensive Cancer Center   (United States)

Author keywords

Atypical lobular neoplasia; Diffuse focal lobular neoplasia; Excision; Lobular carcinoma in situ

Indexed keywords

TAMOXIFEN;

ARTICLE; ATYPICAL LOBULAR HYPERPLASIA; BREAST BIOPSY; BREAST CARCINOMA; CORRELATION ANALYSIS; DISEASE ASSOCIATION; FOLLOW UP; HIGH RISK POPULATION; HUMAN; LOBULAR NEOPLASIA; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MEDICAL RECORD; RETROSPECTIVE STUDY;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; BREAST NEOPLASMS; CARCINOMA, LOBULAR; DECISION SUPPORT TECHNIQUES; FEMALE; FLORIDA; HUMANS; MEDICAL RECORDS; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 33846006188     PISSN: 1075122X     EISSN: 15244741     Source Type: Journal    
DOI: 10.1111/j.1524-4741.2006.00363.x     Document Type: Article

References (20)

1. Arpino G, Allred DC, Mohsin SK, Wiess HL, Conrow D, Elledge RM. Lobular neoplasia on core-needle biopsy - clinical significance. Cancer 2004;101:242-50.
2. Foote FW Jr, Stewart FW. Lobular carcinoma in situ: a rare form of mammary carcinoma. Am J Pathol 1941;17:491.
3. Morrow M, Schnitt SJ, Lobular carcinoma in situ. In: Harris JR, Lipman ME, Morrow M, Osborne CK, eds. Disease of the breast, Chapter 11, 3rd edn. Boston, MA: Lipincott Williams & Wilkins, 2004:369-72.
4. Page DL, Kidd TE, Dupont WD, Simpson JF, Rogers LW. Lobular neoplasia of the breast: higher risk for subsequent invasive cancer predicted by more extensive disease. Hum Pathol 1991;22:1232-39.
5. Frykberg ER. Lobular carcinoma in situ of the breast. Breast J 199;5:296-338.
6. Shin SJ, Rosen PP. Excisional biopsy should be performed if lobular carcinoma in situ is seen on needle core biopsy. Arch Pathol Lab Med 2002;126:697-701.
7. Foster MC, Helvie MA, Gregory NE, Rebner M, Nees AV, Paramagul C. Lobular carcinoma in situ or atypical lobular hyperplasia at core-needle biopsy: is excisional biopsy necessary? Radiology 2004;231:813-19.
8. Lee AHS, Daneley HE, Pinder SE, et al. Excision biopsy findings of patients with breast needle core biopsies reported as suspicious of malignancy (B4) or lesion of uncertain malignant potential (B3). Histopathology 2003;42:331-36.
9. Berg WA, Mrose HE, Ioffe OB. Atypical lobular hyperplasia or lobular carcinoma in situ at core-needle breast biopsy. Radiology 2001;218:503-09.
10. Middleton LP, Grant S, Stephens T, Stelling CB, Sneige N, Sahin AA. Lobular carcinoma in situ diagnosed by core needle biopsy: when it should be excised? Mod Pathol 2003;16: 120-29.
11. Dmytrasz K, Tartter PI, Mizrachy H, Chinitz L, Rosenbaum Smith S, Estabrook A. The significance of lobular hyperplasia at percutaneous breast biopsy. Breast J 2003;9:10-12.
12. O'Driscoll D, Britton P, Bobrow L, Wishart GC, Sinnatamby R, Warren R. Lobular carcinoma in situ on core biopsy. What is the clinical significance? Clin Radiol 2001;56: 216-20.
13. Bauer VP, Ditkoff BA, Schnabel F, Brenin D, El-Tamer M, Smith S. The management of lobular neoplasia identified on percutaneous core breast biopsy. Breast J 2003;9:4-9.
14. Renshaw AA, Cartagena N, Derhagopian RP, Gould EW. Lobular neoplasia in breast core needle biopsy specimens is not associated with an increased risk of ductal carcinoma in situ or invasive carcinoma. Am J Clin Pathol 2002;117:797-99.
15. Fisher ER, Costantino J, Fisher B, et al. Pathologic finding from the national surgical adjuvant breast project (NSABP) protocol B-17: five-year observations concerning lobular carcinoma in situ. Cancer 2004;100:238-44.
16. Liberman L, Sama M, Susnik B, et al. Lobular carcinoma in situ at percutaneous breast biopsy: surgical biopsy findings. AJR 1999;173:291-99.
17. Goldstein NS, Kestin LL, Vicini FA. Clinicopathologic implications of E-cadherin reactivity in patients with LCIS of the breast. Cancer 2001;92:738-47.
18. Cohen MA. Cancer upgrades at excisional biopsy after diagnosis of atypical lobular hyperplasia or lobular carcinoma in situ at core-needle biopsy: some reason why. Radiology 2004;231: 617-21.
19. Lomoschiltz F, Helbich T, Rudas M, et al. Stereotactic core needle biopsy in non-palpable breast lesions. What number is needed? Acta Radiol 2004;45:142-47.
20. Haagensen CD, Bodia C, Haagensen DE. Lobular neoplasia of the breast: higher risk for subsequent invasive cancer predicted by more extensive disease. Hum Pathol 1991;22:1232.